Meta-analysis reveals vitamin D supplementation significantly improves depressive symptoms, suggesting its role in treatment.
Objective To investigate the effect of vitamin D supplementation on depressive symptoms by conducting a meta-analysis of randomized controlled trials. Methods We systematically searched PubMed, EMBASE, the Cochrane Library, CNKI, VIP, Wanfang, and additional databases for relevant literature published between January 1, 2000, and October 31, 2024. Two independent reviewers screened titles, abstracts, and full texts, extracted data, and assessed study quality. RevMan 5.3 software was employed to calculate pooled effect sizes and assess heterogeneity. Results Twenty trials met our inclusion criteria. Meta-analysis using a random-effects model demonstrated that vitamin D supplementation significantly reduced depressive symptom scores compared to controls (standardized mean difference [SMD] = –0.36; 95% confidence interval [CI], –0.52 to –0.20; P < 0.00001). Conclusion Our findings indicate that vitamin D supplementation is associated with a moderate but statistically significant improvement in depressive symptoms. These results support the potential role of vitamin D as an adjunctive treatment for depression, particularly in individuals with baseline deficiency.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: